Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

29 Jul 2021

CEPI and Universiti Malaya announce new collaboration to advance Nipah virus research
The research aims to characterize and better understand immune responses generated against the virus - one of the deadliest pathogens known to infect humans.

Read more

Read article

28 Jul 2021

Largest ever Lassa fever study expands to more countries in West Africa
Up to 23,000 participants will be enrolled into the research programme in Benin, Guinea, Liberia, and Sierra Leone, as well as Nigeria, which began collecting data in December 2020.

Read more

21 Jul 2021

CEPI partners with Shanghai Zerun Biotech to develop COVID-19 variant vaccine
CEPI will provide US$13.1 million to advance development of both COVID-19 prototype and variant vaccine candidates.

Read more

20 Jul 2021

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa
New programme of clinical research in Mozambique aims to support the expanded use of the BBIBP-CorV vaccine in Africa.

Read more

15 Jul 2021

CEPI launches COVAX Marketplace to match buyers and sellers of critical manufacturing supplies and speed up global access to COVID-19 vaccines through COVAX
Innovative ‘marketplace’ aims to accelerate the global production of COVID-19 vaccine doses for COVAX by matching suppliers of critical inputs with vaccine manufacturers who urgently need them.

Read more

06 Jul 2021

CEPI to fund study of COVID-19 vaccine efficacy in immunosuppressed and transplant patients, led by Oslo University Hospital
Study will assess the level of adaptive immune responses to the COVID-19 vaccines in these populations, including B-cell and T-cell responses.

Read more

01 Jul 2021

Joint COVAX Statement on the Equal Recognition of Vaccines

Read more

01 Jul 2021

From lab to potential jab: Clover’s COVID-19 vaccine story
CEPI’s early investment in Clover has been key to accelerating development and equitable access to this promising vaccine.

Read more

Read article

14 Jun 2021

EDCTP and CEPI funding moves IAVI's Lassa fever vaccine candidate into advanced clinical development
Global consortium of expert partners will generate proof -of-concept data to support product licensure and future access.

Read more

11 Jun 2021

G7 summit: an opportunity to conquer the pandemic
As leaders of the world’s wealthiest economies convene in Cornwall, UK, we have a once in a generation moment to build a world better placed to deal with the next pandemic.

Read more

09 Jun 2021

Vaccine specialists and global health experts selected for CEPI's Scientific Advisory Committee
The group will provide key guidance and recommendations on CEPI’s vaccine R&D programmes and broader outbreak response efforts.

Read more

©2021 CEPI. All rights reserved